Eventide Asset Management »

Beam Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.1M 261k 27.22
2023-09-30 $6.3M 261k 24.05
2023-06-30 $15M 459k 31.93
2023-03-31 $14M 459k 30.62
2022-12-31 $10M 267k 39.11
2022-09-30 $13M 267k 47.64